Innoviva (NASDAQ: INVA) reported Q3 EPS of $0.02, $0.25 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $89.51 million versus the consensus estimate of $76.91 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.